22nd Century Group, Inc - Common Stock (XXII)
4.1100
+0.0500 (1.23%)
22nd Century Group Inc is a biotechnology company focused on the development and commercialization of plant-based products, particularly in the areas of hemp and cannabis, as well as products that reduce nicotine levels in tobacco
The company leverages its proprietary genetic technologies to create innovative solutions within these sectors, aiming to transform the way consumers interact with tobacco and cannabis products while promoting public health. Additionally, 22nd Century seeks to advance research and product offerings that cater to a growing demand for reduced-risk alternatives and sustainability in agriculture.
| Previous Close | 4.060 |
|---|---|
| Open | 4.050 |
| Bid | 4.010 |
| Ask | 4.180 |
| Day's Range | 4.010 - 4.250 |
| 52 Week Range | 3.900 - 581.85 |
| Volume | 97,578 |
| Market Cap | 190.54M |
| PE Ratio (TTM) | 0.0396 |
| EPS (TTM) | 103.9 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,490,092 |
